Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Asset Writedowns and Impairment: 2021-2024

Historic Asset Writedowns and Impairment for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $162,000.

  • Biofrontera's Asset Writedowns and Impairment fell 61.76% to $13,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year decrease of 90.67%. This contributed to the annual value of $162,000 for FY2024, which is 32.79% up from last year.
  • Biofrontera's Asset Writedowns and Impairment amounted to $162,000 in FY2024, which was up 32.79% from $122,000 recorded in FY2023.
  • In the past 5 years, Biofrontera's Asset Writedowns and Impairment registered a high of $162,000 during FY2024, and its lowest value of $44,000 during FY2021.
  • Its 3-year average for Asset Writedowns and Impairment is $130,000, with a median of $122,000 in 2023.
  • Data for Biofrontera's Asset Writedowns and Impairment shows a peak YoY surged of 140.91% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Biofrontera's Asset Writedowns and Impairment stood at $44,000 in 2021, then soared by 140.91% to $106,000 in 2022, then rose by 15.09% to $122,000 in 2023, then soared by 32.79% to $162,000 in 2024.